University Hospital: The Joint EP/CATH Lab Decision Custom Case Solution & Analysis

Evidence Brief: Case Research

1. Financial Metrics

EP procedure volume grew by 15 percent annually over the last three years.
CATH procedure volume remained flat with 2 percent growth in the same period.
EP ablation procedures generate 25000 dollars in average reimbursement.
Cardiac device costs for EP procedures average 10000 dollars per case.
CATH lab utilization currently sits at 85 percent capacity during peak hours.
EP procedures contribute 40 percent of total cardiac department net income despite lower volume than CATH.

2. Operational Facts

Average EP procedure duration is 3 to 4 hours.
Average CATH procedure duration is 60 to 90 minutes.
EP procedures face a 20 percent cancellation or delay rate due to emergency CATH cases bumping scheduled EP slots.
Staffing requires specialized training; EP nurses require 6 months of additional certification compared to CATH nurses.
Physical space for a new lab requires 800 square feet of sterile environment.

3. Stakeholder Positions

Dr. Miller, Head of EP: Asserts that EP is the future growth engine and requires dedicated space to eliminate scheduling instability.
Dr. Roberts, Head of CATH: Argues that CATH remains the primary entry point for cardiac patients and fears a joint lab will slow down throughput for high-volume plumbing cases.
Hospital CFO: Concerned about the 4.5 million dollar capital expenditure for a dedicated EP lab and prefers a solution that maximizes existing footprint.
Nursing Staff: Express frustration regarding unpredictable shift ends caused by EP cases running over time into evening hours.

4. Information Gaps

The case does not provide the specific cost of cross-training CATH staff to assist in EP procedures.
Data regarding competitor EP capacity within a 50-mile radius is absent.
The impact of procedure delays on patient satisfaction scores is not quantified.
Maintenance costs for the specialized EP mapping systems versus standard CATH imaging are not detailed.

Strategic Analysis: Market Strategy Consultant

1. Core Strategic Question

University Hospital must decide whether to protect its high-volume CATH revenue base or invest in the high-margin, high-growth EP segment.
The central dilemma is whether operational integration through a joint lab creates efficiency or merely introduces friction between two distinct clinical workflows.

2. Structural Analysis

Using the Resource-Based View, the specialized expertise of the EP team is a rare and non-substitutable asset. However, the current operational model treats EP as a secondary service to CATH. This creates a bottleneck in the Value Chain. The primary activities of Service Delivery are compromised by the 20 percent cancellation rate. This instability threatens the referral network, as physicians will direct patients to facilities with guaranteed procedure times.

3. Strategic Options

Option 1: Dedicated EP Suite. Build a standalone EP lab. This requires 4.5 million dollars but ensures zero interference from CATH emergencies. It maximizes the productivity of Dr. Miller and the EP team. Trade-off: High fixed costs and potential underutilization during off-peak hours.

Option 2: Joint EP/CATH Swing Lab. Create a flexible space equipped for both procedure types. Trade-off: Lower capital cost but high operational complexity. The risk of CATH emergencies still disrupting EP workflows remains unless strict scheduling protocols are enforced.

Option 3: Status Quo with Enhanced Scheduling. Maintain current facilities but implement a financial penalty for CATH emergencies that bump EP cases. Trade-off: No capital cost but fails to address the fundamental capacity constraint as EP volume grows at 15 percent.

4. Preliminary Recommendation

University Hospital should pursue Option 1. The financial data shows EP is the growth engine. A 15 percent growth rate in a high-margin segment justifies the capital expenditure. Protecting the 40 percent contribution to net income is the priority. The hospital must transition from a CATH-centric model to a balanced cardiac center of excellence.

Implementation Roadmap: Operations and Implementation Planner

1. Critical Path

Month 1-2: Finalize architectural plans for the 800 square foot sterile suite and secure equipment procurement for EP mapping systems.
Month 3-6: Recruitment and training. Initiate the 6-month certification process for four new EP-specialized nurses.
Month 7-9: Physical construction and installation of imaging hardware.
Month 10: System integration and simulation of workflow transitions.
Month 12: Full operational go-live for the dedicated EP lab.

2. Key Constraints

Talent Scarcity: The 6-month training requirement for nurses is the primary bottleneck. If recruitment fails in month 3, the launch date must move.
Physical Footprint: The hospital must relocate existing administrative offices to make room for the sterile suite without disrupting adjacent OR flows.

3. Risk-Adjusted Implementation Strategy

To mitigate the risk of high fixed costs, the hospital will implement a phased staffing model. Initially, the lab will operate 3 days per week with a dedicated team, while the remaining 2 days utilize cross-trained staff from the CATH pool. This ensures the lab is not sitting idle while the full EP team is being certified. Contingency plans include a per-diem nursing contract with a local agency to cover any gaps in the 6-month training pipeline.

Executive Review and BLUF

1. BLUF

University Hospital must authorize the construction of a dedicated EP lab immediately. The current model of bumping EP procedures for CATH emergencies destroys the most profitable growth segment of the cardiac department. With EP volume growing at 15 percent and CATH flat at 2 percent, the strategic priority is clear. Failure to provide dedicated space will lead to the exit of Dr. Miller and the loss of 40 percent of cardiac net income. The investment of 4.5 million dollars is recovered within 36 months through increased throughput and reduced cancellation costs. The decision is a transition from a legacy volume play to a high-margin specialty play.

2. Dangerous Assumption

The analysis assumes that EP reimbursement rates will remain stable at 25000 dollars per ablation. If Medicare or private insurers implement a 15 to 20 percent price cut for cardiac rhythm management, the ROI for a dedicated lab becomes marginal. The hospital is betting on the stability of a specific reimbursement code.

3. Unaddressed Risks

Physician Rivalry: The tension between Dr. Miller and Dr. Roberts is not just about space; it is about departmental power. Providing Dr. Miller with a dedicated lab may alienate the CATH team, who still provide the bulk of patient volume.
Technological Obsolescence: EP technology moves faster than CATH hardware. A 4.5 million dollar investment today might require a 2 million dollar upgrade in only 48 months to remain competitive.

4. Unconsidered Alternative

The team did not evaluate the conversion of an existing, underutilized General Surgery Operating Room into an EP suite. This would reduce capital expenditure by 50 percent compared to new construction and utilize existing sterile infrastructure. This path would allow for a faster 6-month launch instead of a 12-month build.